Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Court Tosses $32M Verdict Against Vioxx

Says evidence insufficient that it contributed to Texan's death

By Kevin Spak, Newser Staff

Posted May 14, 2008 1:29 PM CDT

(Newser) – A Texas appellate court threw out a $32 million verdict against Merck today, citing a lack of evidence that Vioxx contributed to a man’s fatal heart attack. Lionel Garza was taking the painkiller when he died in 2001 at age 71, but was also... Read full story »

COMMENTS

Read the comment policy

You need to Log in to Newser to comment. Don't have an account yet? Sign up now!

There are no comments

A snapshot of the day's best news stories.

View Larger Grid

All Today Yesterday Pick a Date

What's Popular Now on Facebook

Cops Shoot Naked Guy Eating Man's Face on Highway

Japanese Artist Serves Up Own Cooked Genitals

Wall Street Journal (Source Grid »)

This is icing on Merck's cake
Wall Street Journal Subscription

Merck downplayed Vioxx risk: Study
National Post (Canada)

Five facts about Vioxx
Reuters

Money • Science

Merck • Vioxx • lawsuit • painkiller • pharmaceutical industry

More Newser Stories

Merck Pays $950M to Settle Vioxx Charges

Feds accused company of illegal marketing

(AP) - Drug maker Merck will pay $950 million to resolve investigations into its marketing of the painkiller Vioxx. The Justice Department said Merck will pay $321.6 million in criminal fines and $628.4 million as a civil settlement agreement. The company also will plead guilty to a misdemeanor charge that it marketed Vioxx as a treatment for rheumatoid arthritis before getting FDA approval. Merck stopped selling Vioxx in 2004 after evidence showed the drug doubled the risk of heart attack and stroke. In 2007, the company paid $4.85 billion to settle around 50,000 Vioxx-related lawsuits. More»

Merck Will Pay $650M to End Discount Probes

Drug company alleged to have kept Medicaid in dark on lowest prices

(NEWSER) - Drug company Merck will dish out $650 million to resolve lawsuits and probes into marketing schemes, the Wall Street Journal reports. Central to the investigations is the company’s “nominal pricing,” which slashed some drug prices by 90% for hospitals but hid the discounts from Medicaid, even though federal law demands that drug companies offer the government program their lowest prices. More»

Merck Recalls 1M Doses of Vaccine for Kids

Drug company finds contamination at its Pennsylvania factory

(NEWSER) - Merck is recalling almost a million doses of a childhood vaccine after it found evidence of contamination at one of its factories, the AP reports. The pharmaceutical giant says no children have been harmed after taking Hib, which prevents meningitis and pneumonia, but the company is recalling its 10 lots and two lots of a combination vaccine for both Hib and hepatitis B. More»

Merck to Settle Suits for $4.85B

Deal will be official once 85% of plaintiffs agree

(NEWSER) - Merck has agreed to shell out $4.85 billion to settle 27,000 Vioxx lawsuits brought by plaintiffs who argued that the pain medication damaged health and caused deaths. The agreement, one of the largest in history, must still be approved by 85% of the plaintiffs, but it's likely to go through, reports the New York Times. More»

Abuse Experts Tremble Over Powerful New Painkillers

Drugs with hydrocodone may cause more addiction

(NEWSER) - A more powerful version of America's second-most abused medicine is likely headed for a doctor's office near you, the AP reports. Four companies are in the patient-testing phase of painkillers that will be up to 10 times more effective than Vicodin thanks to a highly addictive ingredient called hydrocodone. Critics are targeting one pill in particular: Zohydro, which addicts could crush to bypass its time-release effect and receive an immediate high. More»

NEWS FROM OUR PARTNERS

What is Newser?

Face it: there's too much news. At Newser, we choose the most thought-provoking and entertaining stories from hundreds of US and international sources and reduce them to a headline, picture, and two paragraphs. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »

Partnering with: Slate

View Newser on the mobile website

Court Tosses $32M Verdict Against Vioxx

Says evidence insufficient that it contributed to Texan's death

Merck • Vioxx • lawsuit • painkiller • pharmaceutical industry

MOST POPULAR STORIES

[ By Views ]

[ By Comments ]

More Newser Stories

Merck Pays $950M to Settle Vioxx Charges

Feds accused company of illegal marketing

Merck Will Pay $650M to End Discount Probes

Drug company alleged to have kept Medicaid in dark on lowest prices

Merck Recalls 1M Doses of Vaccine for Kids

Drug company finds contamination at its Pennsylvania factory

Merck to Settle Suits for $4.85B

Deal will be official once 85% of plaintiffs agree

Abuse Experts Tremble Over Powerful New Painkillers

Drugs with hydrocodone may cause more addiction

About Us

Site

Community

Site Maps

Tools

More News

What is Newser?